Day One Biopharmaceuticals (DAWN) Enterprise Value
Price: $6.84
Market Cap: $693.26M
Avg Volume: 1.16M
Market Cap: $693.26M
Avg Volume: 1.16M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Day One Biopharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is 1.06B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 1.19B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $12.67, with 93.62M shares outstanding.
- The company has 124.97M in cash and cash equivalents and 2.60M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$1.06B
Market Cap
$1.19B
Total Debt
$2.60M
Cash and Equivalents
$124.97M
Historical Enterprise Value
Day One Biopharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $1.06B | 14.91% | $12.67 | 93.62M | $1.19B | $124.97M | $2.60M |
| September 30, 2024 | $925.81M | -1.89% | $13.93 | 96.62M | $1.35B | $422.76M | $2.62M |
| June 30, 2024 | $943.68M | -16.54% | $13.58 | 87.12M | $1.18B | $239.62M | $190.00K |
| March 31, 2024 | $1.13B | 8.39% | $16.16 | 86.68M | $1.40B | $270.39M | $300.00K |
| December 31, 2023 | $1.04B | 28.15% | $14.6 | 87.23M | $1.27B | $230.78M | $408.00K |
| September 30, 2023 | $813.97M | 15.21% | $12.27 | 85.95M | $1.05B | $241.18M | $514.00K |
| June 30, 2023 | $706.49M | -22.68% | $11.94 | 74.96M | $895.08M | $189.21M | $618.00K |
| March 31, 2023 | $913.73M | -38.94% | $13.37 | 71.97M | $962.28M | $49.27M | $717.00K |
| December 31, 2022 | $1.50B | 14.89% | $21.52 | 73.46M | $1.58B | $85.26M | $813.00K |
| September 30, 2022 | $1.30B | 86.12% | $20.03 | 71.01M | $1.42B | $120.86M | $976.00K |
| June 30, 2022 | $699.78M | 121.03% | $17.9 | 60.76M | $1.09B | $388.88M | $1.04M |
| March 31, 2022 | $316.59M | -58.33% | $9.92 | 58.38M | $579.15M | $262.73M | $171.00K |
| December 31, 2021 | $759.81M | -35.21% | $16.85 | 61.95M | $1.04B | $284.31M | $220.00K |
| September 30, 2021 | $1.17B | 6.56% | $23.73 | 61.93M | $1.47B | $297.16M | $267.00K |
| June 30, 2021 | $1.10B | -15.40% | $22.77 | 61.93M | $1.41B | $310.00M | $313.00K |
| March 31, 2021 | $1.30B | -7.87% | $23.5 | 61.93M | $1.46B | $154.87M | $358.00K |
| December 31, 2020 | $1.41B | -2.98% | $23.5 | 61.93M | $1.46B | $43.73M | $402.00K |
| September 30, 2020 | $1.46B | 0.00% | $23.5 | 61.93M | $1.46B | $- | $- |
| June 30, 2020 | $1.46B | 0.00% | $23.5 | 61.93M | $1.46B | $- | $- |
| March 31, 2020 | $1.46B | - | $23.5 | 61.93M | $1.46B | $- | $- |
Related Metrics
Explore detailed financial metrics and analysis for DAWN.